You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

vector control

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malaria Trial (In2Care EaveTube)

Not yet recruiting
  • Malaria
  • In2Care EaveTube
  • (no location specified)
Feb 24, 2023

Dengue Trial in Singapore (Serious game, Dengue prevention website)

Completed
  • Dengue
  • Serious game
  • Dengue prevention website
  • Singapore, Singapore
    SingHealth Polyclinics - Sengkang
Mar 29, 2022

Malaria Trial in Bamako (Transfluthrin, Placebo)

Active, not recruiting
  • Malaria
  • Transfluthrin
  • Placebo
  • Bamako, Mali
  • +1 more
Apr 29, 2022

Onchocerciasis, Epilepsy Trial in Juba (bi-annual CDTI)

Completed
  • Onchocerciasis
  • Epilepsy
  • bi-annual CDTI
  • Juba, Central, South Sudan
    Amref Health Africa
Mar 1, 2023

Malaria, Anemia Trial in Cove (Bed nets)

Active, not recruiting
  • Malaria
  • Anemia
  • Bed nets
  • Cove, Benin
    Manfred Accrombessi
Aug 23, 2022

COVID-19 Trial in Taizhou (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector), Recombinant Novel Coronavirus

Completed
  • COVID-19
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) -placebo
  • Taizhou, Jiangsu, China
    Taixing City center for Disease Control and Prevention
Oct 28, 2022

COVID-19 Trial in Yancheng (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.5ml, Recombinant Novel

Active, not recruiting
  • COVID-19
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.5ml
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.3ml
  • Yancheng, Jiangsu, China
    Funing Center for Disease Control and Prevention
Oct 28, 2022

Trichuriasis Trial in Kampala (IVM (200 µg/kg) + ALB (400 mg), ALB (400mg))

Not yet recruiting
  • Trichuriasis
  • IVM (200 µg/kg) + ALB (400 mg)
  • ALB (400mg)
  • Kampala, Uganda
    Vector Borne & Neglected Tropical Disease Control Division, Mini
Sep 7, 2023

Malaria,Falciparum Trial in Bagamoyo (ITENs + ITWS)

Recruiting
  • Malaria,Falciparum
  • ITENs + ITWS
  • Bagamoyo, Tanzania
    Vector Control Product Testing Unit Facility
Nov 19, 2021

Stress Urinary Incontinence Trial in United States (Vesair Balloon)

Terminated
  • Stress Urinary Incontinence
  • Vesair Balloon
  • Arlington Heights, Illinois
  • +7 more
Jun 10, 2022

COVID-19 Trial in Nanjing (recombinant Ad5 vectored COVID-19 vaccine, RBD-based protein subunit vaccine (ZF2001) against

Completed
  • COVID-19
  • recombinant Ad5 vectored COVID-19 vaccine
  • +2 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Diseases Control and Prevention
Mar 28, 2022

COVID-19 Trial in Nanjing (Recombinant SARS-CoV-2 Ad5 vectored vaccine, Inactive SARS-CoV-2 vaccine (Vero cell))

Completed
  • COVID-19
  • Recombinant SARS-CoV-2 Ad5 vectored vaccine
  • Inactive SARS-CoV-2 vaccine (Vero cell)
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Mar 28, 2022

Developmental Language Disorder Trial in Stockholm (Grapholearn, Vector, Usual schooling)

Recruiting
  • Developmental Language Disorder
  • Grapholearn
  • +2 more
  • Stockholm, Sweden
    Karolinska Institutet
Mar 16, 2022

Post-transplant Lymphoproliferative Disease, Transplant-Related Hematologic Malignancy Trial in London (Autologous EBV-CTL

Active, not recruiting
  • Post-transplant Lymphoproliferative Disease
  • Transplant-Related Hematologic Malignancy
  • Autologous EBV-CTL transduced with vector SFG-CNA12
  • +2 more
  • London, United Kingdom
  • +1 more
Jan 19, 2022

COVID-19 Trial in Nanjing (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) for Inhalation, Recombinant Novel

Recruiting
  • COVID-19
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) for Inhalation
  • +3 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincal Center for Disease Control and Prevention
Jul 27, 2021

Malaria Trial in Rourkela (Malaria Camps)

Completed
  • Malaria
  • Malaria Camps
  • Rourkela, Odisha, India
    Community Welfare Society Hospital
Dec 21, 2021

Malaria Trial in Washington, Manhica (Actellic CS)

Completed
  • Malaria
  • Actellic CS
  • Washington, District of Columbia
  • +1 more
Sep 15, 2020

COVID-19 Trial in Wuhan (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector))

Completed
  • COVID-19
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
  • Wuhan, Hubei, China
    Hubei Provincial Center for Disease Control and Prevention
Aug 2, 2021

Anesthesia Trial in Milano (TI.VA algorithm: decision support system)

Completed
  • Anesthesia
  • TI.VA algorithm: decision support system
  • Milano, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Jan 19, 2022

Arbovirus Infections Trial in Iquitos (transfluthrin, )

Completed
  • Arbovirus Infections
  • transfluthrin
  • placebo
  • Iquitos, Peru
    University of California, Davis
Mar 3, 2021

Malaria Trial in Windhoek (RACD, RAVC, rfMDA)

Completed
  • Malaria
  • RACD
  • +2 more
  • Windhoek, Namibia
    University of Namibia Multidisciplinary Research Centre
Jul 15, 2020

COVID-19 Trial in Nanjing (Ad5-nCoV-IH, Ad5-nCoV-IM, CoronaVac)

Active, not recruiting
  • COVID-19
  • Ad5-nCoV-IH
  • +2 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Diseases Control and Prevention
Aug 12, 2022

HIV Trial (VRC-HIVDNA016-00-VP, VRC-HIVADV014-00-VP, VRC-HIVDNA016-00-VP )

Withdrawn
  • HIV Infections
  • VRC-HIVDNA016-00-VP
  • +3 more
  • (no location specified)
Oct 28, 2021

Plasmodium Falciparum Malaria, Plasmodium Vivax Malaria Trial in Bangkok (Case Management and Follow-up, Reactive focal mass

Recruiting
  • Plasmodium Falciparum Malaria
  • Plasmodium Vivax Malaria
  • Case Management and Follow-up
  • Reactive focal mass drug administration (rfMDA)
  • Bangkok, Thailand
    Division of Vector Born Diseases, Ministry of Health
Mar 22, 2022

X-Linked Retinitis Pigmentosa Trial (rAAV2tYF-GRK1-hRPGRco)

Not yet recruiting
  • X-Linked Retinitis Pigmentosa
  • rAAV2tYF-GRK1-hRPGRco
  • (no location specified)
May 19, 2021